WHO Grade II Glioma

Explore clinical trials studying WHO Grade II Glioma. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

WHO Grade II Glioma trial results

Recruiting

NCT04479696

Recruiting

NCT04623931

Conditions: Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT04540107

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of California, San Francisco San Francisco, California, United States

Active, Not Recruiting

NCT04458272

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Nagoya University Hospital Nagoya, Aichi-ken, Japan

Kitasato University Hospital Sagamihara, Kanagawa, Japan

Tohoku University Hospital Sendai, Miyagi, Japan

Saitama Medical University International Medical Center Hidaka, Saitama, Japan

Active, Not Recruiting

NCT03749187

Conditions: Astrocytoma, Glioblastoma, Glioma, +16 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Yale University New Haven, Connecticut, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Active, Not Recruiting

NCT03251027

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States